Not recruiting
Dilated cardiomyopathy
Not recruitingStudy of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy
Investigational
Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy
Investigational
- Disease:Dilated cardiomyopathy
- Substances:AB-1002
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:AB-1002



